Keywords Melanoma Adjuvant anti-PD1 Immune-related adverse events Immunotherapy Real-world evidence Seasonal variation 1 Introduction Immune checkpoint inhibitors (ICIs) have changed treatment of both advanced melanoma and other cancers dramatically. By enhancing the antitumor immune response, ICIs significantly improve survival and is now a main pillar in melanoma treatment[1–3] 1. Ascierto, P.A. ∙ Del Vecchio, M. ∙ Robert, C. ...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Lars
Contact Lars, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack